Wendelin Schramm

6PUBLICATIONS
10CO-AUTHORS
Major global burdens of diseaseCross-sectional analysisPredictive and prognostic markersPacific Peoples social determinants of healthGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 27, 2026
The cost-effectiveness of second line diabetes medication added to standard therapy in preventing type 2 diabetes related nephropathy in Germany.

|May 13, 2024
Explorative cost-effectiveness analysis of colorectal cancer recurrence detection with next-generation sequencing liquid biopsy in Spain, France, and Germany.

Wendelin Schramm, Yasmin Hollenbenders, Maximilian Kurscheidt

|Aug 18, 2023
Is there a place for sigmoidoscopy in colorectal cancer screening? A systematic review and critical appraisal of cost-effectiveness models.

Leonie Diedrich, Melanie Brinkmann, Maren Dreier

|Jul 07, 2022
A German Smartphone-Based Self-management Tool for Psoriasis: Community-Driven Development and Evaluation of Quality-of-Life Effects.

Lea C Brandl, Claudia Liebram, Wendelin Schramm

|May 28, 2022
Quality of Life Assessment for Tonsillar Infections and Their Treatment.

Berit Hackenberg, Matthias Büttner, Michelle Schöndorf

|Jul 20, 2021
Assessment of SARS-CoV-2 Infection among Healthcare Workers of a German COVID-19 Treatment Center.

Lionel Larribère, Jelizaveta Gordejeva, Lisa Kuhnhenn

Pageof 1

Frequent Collaborators

2 joint publications

Monika Pobiruchin

1 joint publications

Maximilian Kurscheidt

1 joint publications

Haralampos Gouveris

1 joint publications

Lea C Brandl